Asia’s Premier Partnering Event for the Global Biotechnology Industry
October 11-13, 2017 @ Pacifico Yokohama, Japan.
Since the Nobel Prize was awarded to Professor Shinya Yamanaka for his research on iPS cells in 2012, Japan has been investing heavily in the field of regenerative medicine, and new legislation has made Japan the home of the world’s fastest approval scheme for regenerative medicine-related products.
With Japan set to become a major hotbed for the field of RM, the new exhibition “Regenerative Medicine Japan” returns to Yokohama from October 11 to 13, 2017, for its second year.
Positioned as the leading regenerative medicine-related exhibition in Japan, the event is co-organised by the Japanese RM industrialization taskforce, the Forum for Innovative Regenerative Medicine (FIRM).
It’s also co-located with the long-running pharma and biotech expo BioJapan, which celebrates its 19th edition in 2017!
With the addition of Regenerative Medicine Japan in 2016, the twinned exhibitions continue to strengthen their status as the premier partnering event in Asia for the global biotech industry.
Over 900 organizations from around 30 countries are expected to participate in 2017, to hold an anticipated 8,000 business meetings over the course of the three days.
Register online at: http://www.ics-expo.jp/saisei/